Ergoteles’s Covetrus, Inc. Common Stock CVET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-974,906
Closed -$20.4M 2172
2022
Q3
$20.4M Buy
974,906
+752,338
+338% +$15.7M 0.72% 16
2022
Q2
$4.62M Buy
+222,568
New +$3.96M 0.14% 163
2021
Q3
Sell
-67,200
Closed -$1.81M 1828
2021
Q2
$1.81M Buy
67,200
+48,700
+263% +$1.36M 0.04% 382
2021
Q1
$554K Buy
+18,500
New +$631K 0.02% 469
2020
Q4
Sell
-9,400
Closed -$229K 979
2020
Q3
$229K Buy
+9,400
New +$203K 0.03% 424

Other funds holding CVET

Ergoteles's CVET Position: Q4 2022 in Review

Ergoteles sold out of Covetrus, Inc. Common Stock (CVET) in Q4 2022, closing a stake of 974,906 shares — an estimated $20.4M sold.

Ergoteles first reported a position in CVET in Q3 2020 and held it in 5 quarters. The position peaked at $20.4M in Q3 2022. 5 funds tracked by Wall St. Rank hold CVET as of Q4 2022.

  • Ergoteles reported no remaining Covetrus, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Ergoteles sold 974,906 Covetrus, Inc. Common Stock shares in Q4 2022, an estimated $20.4M.
  • Ergoteles first reported a position in Covetrus, Inc. Common Stock in Q3 2020 and held it in 5 quarters.
  • Ergoteles's Covetrus, Inc. Common Stock position peaked at $20.4M in Q3 2022.
  • 5 funds tracked by Wall St. Rank held Covetrus, Inc. Common Stock as of Q4 2022.

Based on Ergoteles's 13F filing for Q4 2022, filed 14 Feb 2023.